EJNMMI Research

Table 2 Mean absorbed dose calculations of ¹⁷⁷Lu-octreotate in GOT1-bearing nude mice

From: Priming increases the anti-tumor effect and therapeutic window of ¹⁷⁷Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1

Tissue	Mean absorbed dose per administered activity (Gy/MBq)
Tissue	With priming, (5+) 10 MBq	Without priming, 15 MBq
Adrenals	0.11	0.079
Blood	0.00067	0.00069
Kidneys	0.25	0.32
Liver	0.014	0.011
Lungs	0.069	0.038
Pancreas	0.042	0.024
Spleen	0.023	0.012
Tumor	0.51	0.27^a

The mean absorbed dose per administered activity after 10 or 15 MBq ¹⁷⁷Lu-octreotate (Gy/MBq) (with and without priming, n = 9/group), respectively. Values for the 5 + 10 MBq group were estimated from the values for the 10 MBq administrations only
^a n = 8

Back to article page